Novo Nordisk A/S ADR buy Morgan Stanley
Start price
23.01.24
/
50%
€95.40
Target price
23.01.25
€110.32
Performance (%)
29.01%
Price
19.08.24
€122.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 29.01%. A total of €1.08 was paid as dividends for this prediction. This prediction currently runs until 23.01.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | 2.521% | 2.521% |
iShares Core DAX® | 4.097% | 1.280% |
iShares Nasdaq 100 | 5.110% | -0.741% |
iShares Nikkei 225® | 5.333% | -0.280% |
iShares S&P 500 | 3.487% | -0.006% |
Comments by Morgan_Stanley for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for NVO provided by MarketBeat